{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:37:50Z","timestamp":1771486670405,"version":"3.50.1"},"reference-count":105,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.nefro.2019.10.005","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T17:17:34Z","timestamp":1577812654000},"page":"223-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Burden and challenges of heart failure in patients with chronic kidney disease. A call to action"],"prefix":"10.1016","volume":"40","author":[{"given":"Gregorio","family":"Romero-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Ravassa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel Angel","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Garc\u00eda-Trigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Garc\u00eda-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Lavilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paloma L.","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bego\u00f1a","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arantxa","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"Beaumont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gorka","family":"San Jos\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda U.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noelia","family":"Ania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Osacar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Am\u00e9zqueta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"D\u00edez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2019.10.005_bib0530","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.kisu.2017.07.007","article-title":"Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action","volume":"7","author":"Bello","year":"2017","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.nefro.2019.10.005_bib0535","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/S0140-6736(17)30788-2","article-title":"Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy","volume":"390","author":"Levin","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.nefro.2019.10.005_bib0540","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ki.2011.223","article-title":"Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Herzog","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2019.10.005_bib0545","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.kint.2019.02.022","article-title":"Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"95","author":"House","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2019.10.005_bib0550","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archinte.164.6.659","article-title":"Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization","volume":"164","author":"Keith","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.nefro.2019.10.005_bib0555","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCHEARTFAILURE.111.966242","article-title":"Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula","volume":"5","author":"McAlister","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.nefro.2019.10.005_bib0560","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cardfail.2007.03.011","article-title":"High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database","volume":"13","author":"Heywood","year":"2007","journal-title":"J Card Fail"},{"key":"10.1016\/j.nefro.2019.10.005_bib0565","unstructured":"United States Renal Data System. Annual Data Report 2016: Chapter 9: Cardiovascular disease in patients with ESRD. Available at: https:\/\/www.usrds.org\/2016\/view\/v2_09.aspx?zoom_highlight=dialysis+heart+failure [accessed 7.04.19]."},{"key":"10.1016\/j.nefro.2019.10.005_bib0570","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1681\/ASN.2005040439","article-title":"Comorbid conditions in kidney transplantation: association with graft and patient survival","volume":"16","author":"Wu","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0575","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1053\/j.ajkd.2005.06.019","article-title":"De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications","volume":"46","author":"Lentine","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefro.2019.10.005_bib0580","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1097\/01.tp.0000295748.42884.97","article-title":"The impact of left ventricular systolic dysfunction on survival after renal transplantation","volume":"84","author":"Siedlecki","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.nefro.2019.10.005_bib0585","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacc.2004.11.061","article-title":"Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease","volume":"45","author":"Wali","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0590","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","article-title":"Global public health burden of heart failure","volume":"3","author":"Savarese","year":"2017","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.nefro.2019.10.005_bib0595","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.2006101159","article-title":"Reduced kidney function as a risk factor for incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study","volume":"18","author":"Kottgen","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0600","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/jamacardio.2016.4652","article-title":"Absolute rates of heart failure, coronary heart disease, and stroke in chronic kidney disease: an analysis of 3 community-based cohort studies","volume":"2","author":"Bansal","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0605","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1681\/ASN.V1341084","article-title":"Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease","volume":"13","author":"Rigatto","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0610","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/ejhf.821","article-title":"Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"19","author":"Lofman","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.nefro.2019.10.005_bib0615","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/TP.0b013e3182a688e5","article-title":"Predictors of graft failure and death in elderly kidney transplant recipients","volume":"96","author":"Faravardeh","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.nefro.2019.10.005_bib0620","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1097\/TXD.0000000000000640","article-title":"Patterns of care and outcomes in cardiovascular disease after kidney transplantation in the United States","volume":"3","author":"Mathur","year":"2017","journal-title":"Transplant Direct"},{"key":"10.1016\/j.nefro.2019.10.005_bib0625","unstructured":"United States Renal Data System. Annual Data Report 2016: Chapter 6: Medicare expenditures for persons with CKD. Available at: https:\/\/www.usrds.org\/2016\/view\/v2_09.aspx?zoom_highlight=dialysis+heart+failure [accessed 7.04.19]."},{"key":"10.1016\/j.nefro.2019.10.005_bib0630","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.recesp.2014.02.023","article-title":"Impacto econ\u00f3mico de la insuficiencia cardiaca seg\u00fan la influencia de la insuficiencia renal","volume":"68","author":"Sicras Mainar","year":"2016","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0635","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000349972","article-title":"Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI)","volume":"182","author":"Tumlin","year":"2013","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0640","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.semnephrol.2018.08.005","article-title":"Heart failure in end-stage kidney disease: pathophysiology, diagnosis, and therapeutic strategies","volume":"38","author":"Rangaswami","year":"2018","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0645","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41581-018-0101-8","article-title":"Evolving concepts in the pathogenesis of uraemic cardiomyopathy","volume":"15","author":"Wang","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"Suppl. 11","key":"10.1016\/j.nefro.2019.10.005_bib0650","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1038\/ki.2008.512","article-title":"Myocardial fibrosis in chronic kidney disease: potential benefits of torasemide","volume":"74","author":"L\u00f3pez","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2019.10.005_bib0655","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.117.028814","article-title":"Cardiorenal syndrome revisited","volume":"138","author":"Zannad","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.nefro.2019.10.005_bib0660","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejcts.2006.07.006","article-title":"The relationship between myocardial extracellular matrix remodeling and ventricular function","volume":"30","author":"Brower","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.nefro.2019.10.005_bib0665","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajh\/hpy153","article-title":"Increased fibroblast growth factor 23 in heart failure: biomarker, mechanism, or both?","volume":"32","author":"Garc\u00eda-Fern\u00e1ndez","year":"2019","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.nefro.2019.10.005_bib0670","doi-asserted-by":"crossref","first-page":"H715","DOI":"10.1152\/ajpheart.00215.2017","article-title":"Pathophysiology of cardiorenal syndrome in patients with heart failure: potential therapeutic targets","volume":"313","author":"Takahama","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0675","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/HYPERTENSIONAHA.113.02654","article-title":"Association of cardiotrophin-1 with myocardial fibrosis in hypertensive patients with heart failure","volume":"63","author":"L\u00f3pez","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.nefro.2019.10.005_bib0680","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/HJH.0b013e32831ac981","article-title":"Association of plasma cardiotrophin-1 with stage C heart failure in hypertensive patients: potential diagnostic implications","volume":"27","author":"L\u00f3pez","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.nefro.2019.10.005_bib0685","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1161\/HYPERTENSIONAHA.112.194407","article-title":"Cardiotrophin 1 is involved in cardiac, vascular, and renal fibrosis and dysfunction","volume":"60","author":"L\u00f3pez-Andr\u00e9s","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.nefro.2019.10.005_bib0690","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/HYPERTENSIONAHA.118.11874","article-title":"CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) axis in cardiac fibrosis and inflammation","volume":"73","author":"Mart\u00ednez-Mart\u00ednez","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.nefro.2019.10.005_bib0695","first-page":"534","article-title":"Chronic kidney disease and worsening renal function in acute heart failure: different phenotypes with similar prognostic impact?","volume":"5","author":"Palazzuoli","year":"2016","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.nefro.2019.10.005_bib0700","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrcardio.2015.134","article-title":"Pathophysiology and clinical evaluation of acute heart failure","volume":"13","author":"Mentz","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0705","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nefro.2019.10.005_bib0710","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jacc.2014.01.020","article-title":"Proposal for a functional classification system of heart failure in patients with end-stage renal disease: proceedings of the acute dialysis quality initiative (ADQI) XI workgroup","volume":"63","author":"Chawla","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0715","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/ndt\/gfy113","article-title":"Soluble CD146 and B-type natriuretic peptide dissect overhydration into functional components of prognostic relevance in haemodialysis patients","volume":"33","author":"Arrigo","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2019.10.005_bib0720","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/ndt\/gfx197","article-title":"Validation of echocardiographic criteria for the clinical diagnosis of heart failure in chronic kidney disease","volume":"33","author":"Untersteller","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2019.10.005_bib0725","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejheart.2008.07.014","article-title":"State of the art: using natriuretic peptide levels in clinical practice","volume":"10","author":"Maisel","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.nefro.2019.10.005_bib0730","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jacc.2008.11.032","article-title":"Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide","volume":"53","author":"van Kimmenade","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0735","first-page":"629","article-title":"Elevated plasma B-type natriuretic peptide concentrations directly inhibit circulating neprilysin activity in heart failure","volume":"3","author":"Vodovar","year":"2015","journal-title":"JACC: Heart Fail"},{"key":"10.1016\/j.nefro.2019.10.005_bib0740","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/ndt\/gfy066","article-title":"Do plasma neprilysin activity and plasma neprilysin concentration predict cardiac events in chronic kidney disease patients?","volume":"34","author":"Emrich","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2019.10.005_bib0745","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ejhf.1494","article-title":"Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations","volume":"21","author":"Mueller","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.nefro.2019.10.005_bib0750","first-page":"6","article-title":"Risk factors for heart failure in patients with chronic kidney disease: the CRIC (Chronic Renal Insufficiency Cohort) study","author":"He","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.nefro.2019.10.005_bib0755","doi-asserted-by":"crossref","first-page":"e003613","DOI":"10.1161\/CIRCHEARTFAILURE.116.003613","article-title":"Effect of intensive blood pressure treatment on heart failure events in the systolic blood pressure reduction intervention trial","volume":"10","author":"Upadhya","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.nefro.2019.10.005_bib0760","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2215\/CJN.07800811","article-title":"Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR","volume":"7","author":"Rahman","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0765","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefro.2019.10.005_bib0770","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.nefro.2019.10.005_bib0775","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefro.2019.10.005_bib0780","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.117.028268","article-title":"Empagliflozin and clinical outcomes in patients with type 2 diabetes mellitus, established cardiovascular disease, and chronic kidney disease","volume":"137","author":"Wanner","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.nefro.2019.10.005_bib0785","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefro.2019.10.005_bib0790","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefro.2019.10.005_bib0795","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefro.2019.10.005_bib0800","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/sj.ki.5001934","article-title":"The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease","volume":"70","author":"Charytan","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2019.10.005_bib0805","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.296.11.1377","article-title":"Under representation of renal disease in randomized controlled trials of cardio-vascular disease","volume":"296","author":"Coca","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.nefro.2019.10.005_bib0810","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamainternmed.2015.6102","article-title":"Representation of patients with kidney disease in trials of cardiovascular interventions: an updated systematic review","volume":"176","author":"Konstantinidis","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.nefro.2019.10.005_bib0815","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1161\/CIRCULATIONAHA.117.027338","article-title":"Cardiovascular outcome trials in patients with advanced kidney disease: time for action","volume":"135","author":"Zannad","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.nefro.2019.10.005_bib0820","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jchf.2019.02.009","article-title":"Medical management of heart failure with reduced ejection fraction in patients with advanced renal disease","volume":"7","author":"Hein","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.nefro.2019.10.005_bib0825","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jacc.2013.11.031","article-title":"Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data","volume":"63","author":"Damman","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0830","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10741-017-9619-2","article-title":"Heart failure with preserved ejection fraction: a nephrologist-directed primer","volume":"22","author":"Afsar","year":"2017","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.nefro.2019.10.005_bib0835","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/ndt\/gfz053","article-title":"Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies","volume":"34","author":"Rangaswami","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2019.10.005_bib0840","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2007.09.043","article-title":"Elevated intra-abdominal pressure in acute decompensated heart failure","volume":"51","author":"Mullens","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0845","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0850","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.jacc.2017.03.528","article-title":"Extracorporeal ultrafiltration for fluid overload in heart failure: current status and prospects for further research","volume":"69","author":"Costanzo","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0855","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cardfail.2016.06.423","article-title":"Relevance of changes in serum creatinine during a heart failure trial of decongestive strategies: insights from the DOSE trial","volume":"22","author":"Brisco","year":"2016","journal-title":"J Card Fail"},{"key":"10.1016\/j.nefro.2019.10.005_bib0860","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11897-018-0406-8","article-title":"Cardiorenal interactions revisited: how to improve heart failure outcomes in patients with chronic kidney disease","volume":"15","author":"Arrigo","year":"2018","journal-title":"Circ Heart Fail Rep"},{"key":"10.1016\/j.nefro.2019.10.005_bib0865","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","article-title":"Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure","volume":"49","author":"Costanzo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0870","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jchf.2015.08.005","article-title":"Aquapheresis versus intravenous diuretics and hospitalizations for heart failure","volume":"4","author":"Costanzo","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.nefro.2019.10.005_bib0875","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cardfail.2013.11.004","article-title":"Continuous ultrafiltration for congestive heart failure: the CUORE trial","volume":"20","author":"Marenzi","year":"2014","journal-title":"J Card Fail"},{"key":"10.1016\/j.nefro.2019.10.005_bib0880","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/ejhf.1158","article-title":"Comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF","volume":"20","author":"Grodin","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.nefro.2019.10.005_bib0885","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000380915","article-title":"Peritoneal dialysis in patients with refractory congestive heart failure: a systematic review","volume":"5","author":"Lu","year":"2015","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.nefro.2019.10.005_bib0890","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000337476","article-title":"Myocardial stunning with hemodialysis: clinical challenges of the cardiorenal patient","volume":"2","author":"Zuidema","year":"2012","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.nefro.2019.10.005_bib0895","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1161\/01.CIR.66.6.1146","article-title":"The stunned myocardium: prolonged, postischemic ventricular dysfunction","volume":"66","author":"Braunwald","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.nefro.2019.10.005_bib0900","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.2215\/CJN.04470709","article-title":"Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function","volume":"4","author":"Burton","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0905","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1681\/ASN.2014020222","article-title":"Association of mortality risk with various definitions of intradialytic hypotension","volume":"26","author":"Flythe","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0910","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.2215\/CJN.02680314","article-title":"Intradialytic hypotension and risk of cardiovascular disease","volume":"9","author":"Stef\u00e1nsson","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0915","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.nefro.2015.03.001","article-title":"Cardiac complications of arteriovenous fistulas in patients with end-stage renal disease","volume":"35","author":"Alkhouli","year":"2015","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefro.2019.10.005_bib0920","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1542-4758.2010.00478.x","article-title":"The long-term effects of arteriovenous fistula creation on the development of pulmonary hypertension in hemodialysis patients","volume":"14","author":"Unal","year":"2010","journal-title":"Hemodial Int"},{"key":"10.1016\/j.nefro.2019.10.005_bib0925","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1159\/000320755","article-title":"Right ventricular dysfunction in patients with end-stage renal disease","volume":"32","author":"Paneni","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0930","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.semnephrol.2012.10.006","article-title":"High-output heart failure: how to define it, when to treat it, and how to treat it","volume":"32","author":"Wasse","year":"2012","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0935","doi-asserted-by":"crossref","first-page":"315","DOI":"10.12659\/AOT.903414","article-title":"Supplementary administration of everolimus reduces cardiac systolic function in kidney transplant recipients","volume":"22","author":"Tsujimura","year":"2017","journal-title":"Ann Transplant"},{"key":"10.1016\/j.nefro.2019.10.005_bib0940","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3909\/ricm0891","article-title":"A call to action to develop integrated curricula in cardiorenal medicine","volume":"18","author":"Ronco","year":"2017","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.nefro.2019.10.005_bib0945","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000490744","article-title":"Cardionephrology: proposal for a futuristic educational approach to a contemporary need","volume":"8","author":"Kazory","year":"2018","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.nefro.2019.10.005_bib0950","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1053\/j.ajkd.2017.12.006","article-title":"Management of heart failure in advancing CKD: core curriculum 2018","volume":"72","author":"House","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefro.2019.10.005_bib0955","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrneph.2014.243","article-title":"Cardiac imaging in patients with chronic kidney disease","volume":"11","author":"Chiu","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0960","first-page":"31","article-title":"Guidelines of the Spanish Society of Nephrology: the kidney and cardiovascular disease. Short version","volume":"26","author":"Mar\u00edn","year":"2006","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefro.2019.10.005_bib0965","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.recesp.2016.06.010","article-title":"Classification and quality standards of heart failure units: Scientific consensus of the Spanish Society of Cardiology","volume":"69","author":"Anguita S\u00e1nchez","year":"2016","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0970","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.nefro.2019.10.005_bib0975","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijnurstu.2017.06.008","article-title":"Effects of self-management on chronic kidney disease: a meta-analysis","volume":"74","author":"Lin","year":"2017","journal-title":"Int J Nurs Stud"},{"key":"10.1016\/j.nefro.2019.10.005_bib0980","doi-asserted-by":"crossref","first-page":"e019814","DOI":"10.1136\/bmjopen-2017-019814","article-title":"Self-management interventions for adults with chronic kidney disease: a scoping review","volume":"8","author":"Donald","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.nefro.2019.10.005_bib0985","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12882-019-1309-y","article-title":"Self-management interventions for chronic kidney disease: a systematic review and meta-analysis","volume":"20","author":"Peng","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nefro.2019.10.005_bib0990","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/eurjhf\/hfq219","article-title":"Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology","volume":"13","author":"Lainscak","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"Suppl. 1","key":"10.1016\/j.nefro.2019.10.005_bib0995","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1755-6686.2010.00158.x","article-title":"Heart failure and chronic kidney disease: an integrated care approach","volume":"36","author":"Jenkins","year":"2010","journal-title":"J Ren Care"},{"key":"10.1016\/j.nefro.2019.10.005_bib1000","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.pop.2019.05.008","article-title":"Palliative care approach to chronic diseases: end stages of heart failure, chronic obstructive pulmonary disease, liver failure, and renal failure","volume":"46","author":"Mechler","year":"2019","journal-title":"Prim Care"},{"key":"10.1016\/j.nefro.2019.10.005_bib1005","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1681\/ASN.2013050567","article-title":"Predialysis health, dialysis timing, and outcomes among older United States adults","volume":"25","author":"Crews","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2019.10.005_bib1010","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/j.jrn.2014.10.015","article-title":"Timing of dialysis initiation: when to start? Which treatment?","volume":"25","author":"Leurs","year":"2015","journal-title":"J Ren Nutr"},{"issue":"S1","key":"10.1016\/j.nefro.2019.10.005_bib1015","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/j.ajkd.2016.05.025","article-title":"Intensive hemodialysis, left ventricular hypertrophy, and cardiovascular disease","volume":"68","author":"McCullough","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"S1","key":"10.1016\/j.nefro.2019.10.005_bib1020","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1053\/j.ajkd.2016.05.021","article-title":"Intensive hemodialysis and treatment complications and tolerability","volume":"68","author":"Morfin","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefro.2019.10.005_bib1025","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2215\/CJN.00200115","article-title":"Randomized controlled trial of individualized dialysate cooling for cardiac protection in hemodialysis patients","volume":"10","author":"Odudu","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2019.10.005_bib1030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/hdi.12606","article-title":"Can a renal nurse assess fluid status using ultrasound on the inferior vena cava? A cross-sectional interrater study","volume":"22","author":"Steinwandel","year":"2018","journal-title":"Hemodial Int"},{"key":"10.1016\/j.nefro.2019.10.005_bib1035","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1111\/jocn.14804","article-title":"Does the intravascular volume status in haemodialysis patients measured by inferior vena cava ultrasound correlate with bioimpedance spectroscopy?","volume":"28","author":"Steinwandel","year":"2019","journal-title":"J Clin Nurs"},{"key":"10.1016\/j.nefro.2019.10.005_bib1040","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1161\/CIRCULATIONAHA.119.040361","article-title":"Should we ligate arteriovenous fistulas in asymptomatic patients after kidney transplantation?","volume":"139","author":"Stoumpos","year":"2019","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"10.1016\/j.nefro.2019.10.005_bib1045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nefro.2017.11.004","article-title":"Spanish clinical guidelines on vascular access for haemodialysis","volume":"37","author":"Ibeas","year":"2017","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefro.2019.10.005_bib1050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.kint.2017.10.002","article-title":"Resuscitation for the specialty of nephrology: is cardionephrology the answer?","volume":"93","author":"Rangaswami","year":"2018","journal-title":"Kidney Int"}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699519301961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699519301961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:53:50Z","timestamp":1759323230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699519301961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":105,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0211699519301961"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2019.10.005","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Burden and challenges of heart failure in patients with chronic kidney disease. A call to action","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2019.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}